NEXENTIS TECHNOLOGIES INC. Cash, Including Discontinued Operations
NEXENTIS TECHNOLOGIES INC. (NXTS) had Cash, Including Discontinued Operations of $31.00 thousand as of 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Cash
us-gaap:CashIncludingDiscontinuedOperations · last filed 2026-03-31
- 2024-12-31: Cash, Including Discontinued Operations $31.00K.
| Period end | Cash, Including Discontinued Operations |
|---|---|
| 2024-12-31 | $31.00K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |